BMY vs TPR · P/E 17, rev $24.46B vs P/E 46, rev $8.00B
Bristol-Myers Squibb Company (BMY) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the BMY and TPR stock pages for the full models.
Not investment advice.